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The interstitial space refers to the area in the lung between the alveolar epithelium 
and capillary endothelium.  Interstitial lung disease is a broad category of inflammatory 
and fibrotic pulmonary diseases involving primarily the interstitial space.  Idiopathic 
pulmonary fibrosis (IPF), previously known as cryptogenic fibrosing alveolitis, is a form 
of interstitial lung disease that has been recognized in dogs, cats and humans and is 
characterized by inflammation and fibrosis of the pulmonary interstitium and alveolus.  
Histologic features of IPF are termed unusual interstitial pneumonia and include 
interstitial fibrosis with foci of fibroblasts or myofibroblasts, metaplasia of alveolar 
epithelium and interstitial smooth muscle hyperplasia.  The diagnosis and treatment of 
IPF can be difficult since permanent loss of pulmonary function has often occurred 
before clinical signs are recognized.  This condition is well characterized in humans and 
is associated with a poor prognosis regardless of treatment.   
 
IDIOPATHIC PULMONARY FIBROSIS IN CATS 
 
Idiopathic pulmonary fibrosis is a relatively uncommon condition in cats.  The 
mean age of cats with IPF is 8 years with no apparent breed or sex predilection.  Cats 
with IPF most commonly present for respiratory distress or cough and the duration of 
these signs is typically less than 6 months.  Physical examination findings include 
tachypnea, increased inspiratory or mixed inspiratory and expiratory effort, and 
adventitial lung sounds.  Generally, results of clinicopathologic and infectious disease 
assessment are nonspecific in nature.  Mild neutrophilic inflammation may be noted on 
cytologic analysis of bronchoalveolar lavage fluid in some cats.  Radiographic findings 
include dense patchy or diffuse interstitial, bronchial or alveolar infiltrates.  Definitive 
diagnosis is based on histologic evaluation of lung tissue. A variety of treatments have 
been proposed for the treatment of IPF in cats including corticosteroids and 
bronchodilators.  Currently, there is no published evidence that any treatment has a 
positive or negative impact on the clinical outcome.  Prognosis for cats with IPF is poor 
to grave.  In one retrospective study, more than 50% of cats with IPF died or were 
euthanatized within weeks of diagnosis while only 30% survived for a year or more after 
diagnosis. 
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IDIOPATHIC PULMONARY FIBROSIS IN DOGS 
Idiopathic pulmonary fibrosis is an uncommon condition in dogs.  Most dogs with 
IPF are middle aged to older with no sex predilection.  While IPF is considered rare in the 
general canine population, the condition appears to be prevalent in terrier breeds, 
especially West Highland white terriers. Clinical signs can include coughing, tachypnea, 
dyspnea and cyanosis.  Inspiratory crackles are the most common physical examination 
finding in dogs with IPF.  Clinicopathologic findings are usually nonspecific.  Some dogs 
will have evidence of concurrent chronic bronchitis on bronchoalveolar lavage fluid 
analysis.  Radiographically, generalized interstitial or bronchointerstitial pattern are 
common findings while patchy alveolar infiltrates are identified less frequently.  Diffuse 
ground-glass opacities in all lung lobes on high resolution CT is supportive of the 
diagnosis of IPF in dogs.  Definitive diagnosis is based on histologic evaluation of lung 
tissue.  As in cats, there is currently no effective treatment for IPF in dogs.  A 
combination of corticosteroids and bronchodilators has been anecdotally recommended.  
Similarly, there is little information pertaining to prognosis in dogs with IPF.  However, 
median survival of 15.5 months (range 3-41 months) has been reported in one study of 
West Highland white terriers with IPF.   
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